ArticleMolecular and clinical oncology2019

Survival outcome of combined GnRH agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer.

Doonyapat Sa-Nguanraksa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.